Iowa Cannabis Advocacy & Opposition Groups

Last verified: April 2026

Reform & Patient Advocacy

Iowa NORML

The state chapter of the National Organization for the Reform of Marijuana Laws. Tracks arrest data and racial-disparity statistics, supports legislative reform, and coordinates patient and consumer testimony at the Capitol.

• Web: norml.org/iowa

ACLU of Iowa

Executive Director Mark Stringer; Legal Director Rita Bettis Austen. The ACLU of Iowa leads racial-disparity litigation and policy advocacy. Its national report “A Tale of Two Countries” established the headline figure that a Black Iowan is 7.3 times more likely to be arrested for marijuana possession than a white Iowan — despite essentially equal usage rates. County-level disparities run higher: Pottawattamie 17x, Dubuque 13x, Scott (Quad Cities) ~13x, Cerro Gordo 11x, Linn (Cedar Rapids) ~10x.

• Address: 505 Fifth Avenue, Suite 808, Des Moines, IA 50309
• Phone: (515) 243-3988
• Web: aclu-ia.org

A Black Iowan is 7.3 times more likely to be arrested for marijuana possession than a white Iowan, despite essentially equal usage rates. In Pottawattamie County the disparity reaches 17x; in Dubuque and Scott counties it exceeds 13x.

ACLU of Iowa & ACLU national report, "A Tale of Two Countries"

Iowa Cannabis Patient Network (ICPN) / Iowa Cannabis Patient Advocates

Patient advocacy organization (also known in legislative testimony as Iowa Cannabis Patient Advocates). Documents cap-related undertreatment under the 4.5-gram-per-90-days ceiling, lobbies for flower expansion, telemedicine certification, and meaningful raises to the THC purchase ceiling. Coordinates patient testimony with allied groups including Quad Cities Patients United, a Mississippi River-area patient coalition.

Iowans for Medical Marijuana

Founded by Carl Olsen, a Des Moines-based cannabis-rights advocate, in 1990. Olsen was an original 1972 Marijuana Rescheduling Petitioner before the DEA. He pushed the Iowa Medical Cannabidiol Board in 2019 to recommend a federal exemption for Iowa, citing 21 U.S.C. §822(d) and 21 C.F.R. §1307.03 — the same authority used for peyote in Native American religious practice. The 2020 Iowa Acts ch. 1116 §31 codified the request, and Iowa HHS submitted the federal waiver application in 2021. The DEA has not responded as of April 2026 — nearly five years later. Olsen has filed multiple state lawsuits seeking judicial review of the program’s structure.

• Web: iowamedicalmarijuana.org

Marijuana Policy Project — Iowa

National advocacy organization with state-tracking pages for Iowa policy.

• Web: mpp.org/states/iowa

Regulators & Oversight

Iowa Department of Health and Human Services — Office of Medical Cannabidiol (Bureau of Cannabis Regulation)

The state regulator for the Chapter 124E medical program. Handles patient-card applications, manufacturer and dispensary licensing, lab-testing rules, and rule-making. Bureau Chief Owen Parker, MPH.

• Address: Lucas State Office Building, 321 East 12th Street, Des Moines, IA 50319
• Phone: (515) 725-2076
• Toll-free: 1-877-214-9313
• Email: medical.cannabis@hhs.iowa.gov / medicalcannabidiol@idph.iowa.gov
• Web: hhs.iowa.gov/health-prevention/medical-cannabis

Iowa Medical Cannabidiol Board

An 8-member advisory board appointed by the governor and legislative leaders. Reviews petitions to add new qualifying conditions, recommends program improvements to the General Assembly, and meets quarterly. Board recommendations — including permitting vaporizable raw flower, expanding telemedicine certification, allowing independent testing labs, and pursuing federal waivers — have largely gone unenacted by the legislature.

Institutional Opposition

Iowa Sheriffs’ and Deputies’ Association

Generally opposed to expansion. Cites workplace impairment, OWI metabolite-detection limitations, and federal Schedule I status as reasons for opposition. Frequent committee testimony.

Iowa Peace Officers Association

Opposes adult-use legalization. Aligned with sheriffs’ association on workforce drug-testing concerns.

Iowa Family Policy Center

Religious/conservative advocacy organization. Opposes both medical-program expansion and adult-use legalization.

Iowa Hospital Association

Has historically opposed expansion citing workforce and clinical concerns. Hospitals are subject to federal Schedule I conflicts under DEA registration and Medicare/Medicaid participation requirements.

Smart Approaches to Marijuana — Iowa

State chapter of the national anti-legalization organization. Coordinates with Family Policy Center and law-enforcement associations on legislative testimony.

Hemp Industry

Iowa Hemp Association

Represents licensed hemp growers and processors operating under Iowa Code Chapter 204 and the Iowa Hemp Act (SF 599, 2019, separate from the medical cannabis SF 599 of 2022). Activity intensified after HF 2605 (2024) restricted consumable hemp products.

Iowa Cannabis Industry Association

Industry trade association — verify current activity status before contacting; Iowa’s small program (two manufacturers, five dispensaries) supports limited industry organizing.

Advocacy Ledger

Where Advocacy Has Moved Policy

Reform advocacy has produced incremental wins. The 2020 cap-restructuring (HF 2589, raising the ceiling to 4.5 grams of THC per 90 days from a 3% concentration cap) and the 2022 expansion (SF 599 adding severe pediatric autism and severe pain) followed years of patient testimony. The Iowa Medical Cannabidiol Board’s federal-waiver request — pushed by Carl Olsen — was codified in 2020 Iowa Acts ch. 1116 §31 and submitted to the DEA in 2021.

Where advocacy has not moved policy: smokable-flower expansion, telemedicine certification, independent testing labs, the dispensary cap, Iowa Code §730.5 workplace protections for patients, and the §321J zero-tolerance OWI rule for THC metabolites all remain unchanged through 2026. The ACLU’s 7.3x racial-disparity figure is a fixture of legislative testimony but has not produced decriminalization legislation.

Get Involved

Advocates direct Iowans to four entry points:

• Patient testimony coordination through Iowa Cannabis Patient Network and Quad Cities Patients United.
• Public comment on Office of Medical Cannabidiol rule-making through Iowa HHS.
• Legislative subcommittee testimony coordinated through Iowa NORML and Iowans for Medical Marijuana.
• Civil-liberties and forfeiture matters through the ACLU of Iowa.

Explore Reform & Politics